Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Scand J Rheumatol

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    June 2017
  1. CUPPEN B, Fritsch-Stork R, Eekhout I, de Jager W, et al
    Proteomics to predict the response to tumour necrosis factor-alpha inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score.
    Scand J Rheumatol. 2017 Jun 26:1-10. doi: 10.1080/03009742.2017.1309061.
    PubMed     Text format     Abstract available


    May 2017
  2. BERTHOLD E, Mansson B, Gullstrand B, Geborek P, et al
    Tumour necrosis factor-alpha/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.
    Scand J Rheumatol. 2017 May 9:1-5. doi: 10.1080/03009742.2017.1290822.
    PubMed     Text format     Abstract available


  3. OSTGARD RD, Glerup H, Jurik AG, Kragstrup TW, et al
    Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients.
    Scand J Rheumatol. 2017 May 9:1-5. doi: 10.1080/03009742.2017.1286382.
    PubMed     Text format     Abstract available


  4. KONO M, Yasuda S, Kono M, Atsumi T, et al
    Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.
    Scand J Rheumatol. 2017 May 8:1-3. doi: 10.1080/03009742.2017.1297482.
    PubMed     Text format    


    April 2017
  5. RANNIO T, Asikainen J, Hannonen P, Yli-Kerttula T, et al
    Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
    Scand J Rheumatol. 2017 Apr 3:1-7. doi: 10.1080/03009742.2016.1266029.
    PubMed     Text format     Abstract available


    March 2017
  6. LESUIS N, Verhoef LM, Nieboer LM, Bruyn GA, et al
    Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.
    Scand J Rheumatol. 2017;46:152-155.
    PubMed     Text format     Abstract available


    February 2017
  7. KOBAYASHI Y, Kobayashi H, Giles J, Yokoe I, et al
    Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imaging.
    Scand J Rheumatol. 2017 Feb 20:1-2. doi: 10.3109/03009742.2016.1173722.
    PubMed     Text format    


  8. NGUYEN M, Lindegaard H, Hendricks O, Friis-Moller N, et al
    Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
    Scand J Rheumatol. 2017 Feb 1:1-8. doi: 10.1080/03009742.2016.1242774.
    PubMed     Text format     Abstract available


    January 2017
  9. AXELSEN MB, Eshed I, Ostergaard M, Hetland ML, et al
    Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis.
    Scand J Rheumatol. 2017 Jan 26:1-10. doi: 10.1080/03009742.2016.1231338.
    PubMed     Text format     Abstract available


  10. LOGSTRUP BB, Masic D, Laurbjerg TB, Blegvad J, et al
    Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study.
    Scand J Rheumatol. 2017 Jan 25:1-9. doi: 10.1080/03009742.2016.1249941.
    PubMed     Text format     Abstract available


  11. BALLESTER C, Grobost V, Roblot P, Pourrat O, et al
    Pregnancy and primary Sjogren's syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies.
    Scand J Rheumatol. 2017;46:56-63.
    PubMed     Text format     Abstract available


  12. KOH JH, Kwok SK, Lee J, Son CN, et al
    Pain, xerostomia, and younger age are major determinants of fatigue in Korean patients with primary Sjogren's syndrome: a cohort study.
    Scand J Rheumatol. 2017;46:49-55.
    PubMed     Text format     Abstract available


    December 2016
  13. CHIU HY, Wang IT, Huang WF, Tsai YW, et al
    Risk of varicocele in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic disease: a population-based case-control study.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  14. WEITOFT T, Larsson A, Saxne T, Manivel VA, et al
    Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  15. AALTONEN KJ, Joensuu JT, Pirila L, Kauppi M, et al
    Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  16. DOMINGUEZ-MOZO MI, Toledano-Martinez E, Rodriguez-Rodriguez L, Garcia-Montojo M, et al
    JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.
    Scand J Rheumatol. 2016;45:507-511.
    PubMed     Text format     Abstract available


    October 2016
  17. MOLLER-BISGAARD S, Ejbjerg BJ, Eshed I, Horslev-Petersen K, et al
    Effect of a treat-to-target cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  18. SZEREMETA A, Jura-Poltorak A, Komosinska-Vassev K, Zon-Giebel A, et al
    The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  19. ADELINO JE, Addobbati C, Pontillo A, Fragoso TS, et al
    A genetic variant within SLC30A6 has a protective role in the severity of rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  20. SHIRI R
    Arthritis as a risk factor for carpal tunnel syndrome: a meta-analysis.
    Scand J Rheumatol. 2016;45:339-46.
    PubMed     Text format     Abstract available


  21. MOREIRA E, Jones A, Oliveira HA, Jennings F, et al
    Effectiveness of insole use in rheumatoid feet: a randomized controlled trial.
    Scand J Rheumatol. 2016;45:363-70.
    PubMed     Text format     Abstract available


  22. PERDAN-PIRKMAJER K, Pirkmajer S, Thevis M, Thomas A, et al
    Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.
    Scand J Rheumatol. 2016;45:347-55.
    PubMed     Text format     Abstract available


    September 2016
  23. KRABBE S, Bolce R, Brahe CH, Dohn UM, et al
    Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  24. MORTENSEN KL, Krogh TP, Jensen-Fangel S, Hauge EM, et al
    Severe acute pancytopaenia in a patient with rheumatoid arthritis complicated by fatal invasive pulmonary aspergillosis.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  25. MORITA T, Shima Y, Kakigano A, Ogata A, et al
    Serum anti-citrullinated protein antibodies of a mother with rheumatoid arthritis pass through the placenta but do not cause arthritis in her neonate.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  26. CHATZIDIONYSIOU K
    Optimizing biological treatments for rheumatoid arthritis.
    Scand J Rheumatol. 2016;45.
    PubMed     Text format     Abstract available


    July 2016
  27. ROME K, Clark H, Gray J, McMeekin P, et al
    Clinical effectiveness and cost-effectiveness of foot orthoses for people with established rheumatoid arthritis: an exploratory clinical trial.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  28. KNEEPKENS EL, van den Oever I, Plasencia CH, Pascual-Salcedo D, et al
    Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  29. MYRTHIANOU E, Zervou MI, Budu-Aggrey A, Eliopoulos E, et al
    Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  30. TUOMINEN S, Leino M, Pirila L, Tuominen R, et al
    Measuring the economic value of morning stiffness: consistency over 1 year.
    Scand J Rheumatol. 2016;45:294-8.
    PubMed     Text format     Abstract available


    June 2016
  31. AUSTAD C, Kvien TK, Olsen IC, Uhlig T, et al
    Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  32. HILLEN MR, Moret FM, van der Wurff-Jacobs K, Radstake T, et al
    Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  33. OLSSON P, Theander E, Bergstrom U, Jovinge S, et al
    Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  34. LEON L, Rodriguez-Rodriguez L, Rosales Z, Gomez A, et al
    Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  35. VOLCHENKOV R, Dung Cao M, Elgstoen KB, Goll GL, et al
    Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  36. VERGARA F, Rosa J, Orozco C, Bertiller E, et al
    Evaluation of learned helplessness, self-efficacy and disease activity, functional capacity and pain in Argentinian patients with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  37. SVENSSON B, Andersson M, Forslind K, Ajeganova S, et al
    Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  38. DING S, Duan H, Fang F, Shen H, et al
    CTGF promotes articular damage by increased proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  39. CHRISTENSEN AW, Rifbjerg-Madsen S, Christensen R, Dreyer L, et al
    Non-nociceptive pain in rheumatoid arthritis is frequent and affects disease activity estimation: cross-sectional data from the FRAME study.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  40. KOIVUNIEMI R, Paimela L, Suomalainen R, Leirisalo-Repo M, et al
    Renal diseases in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


    February 2016
  41. HALLERT E, Husberg M, Kalkan A, Bernfort L, et al
    Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  42. IWATA T, Ito H, Furu M, Hashimoto M, et al
    Systemic effects of surgical intervention on disease activity, daily function, and medication in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  43. UUTELA T, Kautiainen H, Jarvenpaa S, Hakala M, et al
    Self-rated health in patients with rheumatoid arthritis is associated with health-related quality of life but not with clinical variables.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  44. NORDAL HH, Brun JG, Hordvik M, Eidsheim M, et al
    Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  45. LINDEGAARD HM, Johansen P, Grondal G, Jensen EC, et al
    Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  46. LEE H, Kim Y, Han K, Oh EJ, et al
    Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Scand J Rheumatol. 2016;45:122-8.
    PubMed     Text format     Abstract available


  47. KOSKENPATO K, Ainola M, Przybyla B, Kouri VP, et al
    Diminished salivary epidermal growth factor secretion: a link between Sjogren's syndrome and autoimmune gastritis?
    Scand J Rheumatol. 2016;45:118-21.
    PubMed     Text format     Abstract available


  48. BIERKARRE H, Harder J, Cuthbert R, Emery P, et al
    Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity.
    Scand J Rheumatol. 2016;45:188-96.
    PubMed     Text format     Abstract available


  49. NUNOKAWA T, Yokogawa N, Shimada K, Enatsu K, et al
    The use of muscle biopsy in the diagnosis of systemic vasculitis affecting small to medium-sized vessels: a prospective evaluation in Japan.
    Scand J Rheumatol. 2016;45:210-4.
    PubMed     Text format     Abstract available


    December 2015
  50. MADSEN SG, Danneskiold-Samsoe B, Stockmarr A, Bartels EM, et al
    Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: a systematic review.
    Scand J Rheumatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  51. DIMITROULAS T, Sandoo A, Hodson J, Smith J, et al
    Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.
    Scand J Rheumatol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  52. ALTEN R, Holt R, Grahn A, Rice P, et al
    Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.
    Scand J Rheumatol. 2015;44:354-8.
    PubMed     Text format     Abstract available


  53. HA YJ, Kang EJ, Lee SW, Park YB, et al
    Serum leucine-rich alpha2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Scand J Rheumatol. 2015;44:399-403.
    PubMed     Text format     Abstract available


  54. KONTNY E, Janicka I, Skalska U, Maslinski W, et al
    The effect of multimeric adiponectin isoforms and leptin on the function of rheumatoid fibroblast-like synoviocytes.
    Scand J Rheumatol. 2015;44:363-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: